122 related articles for article (PubMed ID: 6651397)
1. First results on the effects of MAO inhibition on cognitive functioning in elderly depressed patients.
Georgotas A; Reisberg B; Ferris S
Arch Gerontol Geriatr; 1983 Nov; 2(3):249-54. PubMed ID: 6651397
[TBL] [Abstract][Full Text] [Related]
2. Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors.
Georgotas A; Friedman E; McCarthy M; Mann J; Krakowski M; Siegel R; Ferris S
Biol Psychiatry; 1983 Feb; 18(2):195-205. PubMed ID: 6830930
[TBL] [Abstract][Full Text] [Related]
3. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial.
Jarrett RB; Schaffer M; McIntire D; Witt-Browder A; Kraft D; Risser RC
Arch Gen Psychiatry; 1999 May; 56(5):431-7. PubMed ID: 10232298
[TBL] [Abstract][Full Text] [Related]
4. Response of psychotic and nonpsychotic depression to phenelzine.
Janicak PG; Pandey GN; Davis JM; Boshes R; Bresnahan D; Sharma R
Am J Psychiatry; 1988 Jan; 145(1):93-5. PubMed ID: 3337297
[TBL] [Abstract][Full Text] [Related]
5. Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement.
Celada P; Pérez J; Alvarez E; Artigas F
J Clin Psychopharmacol; 1992 Oct; 12(5):309-15. PubMed ID: 1282522
[TBL] [Abstract][Full Text] [Related]
6. Prediction of response to nortriptyline and phenelzine by platelet MAO activity.
Georgotas A; McCue RE; Friedman E; Cooper T
Am J Psychiatry; 1987 Mar; 144(3):338-40. PubMed ID: 3826434
[TBL] [Abstract][Full Text] [Related]
7. Treating DSM-IV depression with atypical features.
Stewart JW; Thase ME
J Clin Psychiatry; 2007 Apr; 68(4):e10. PubMed ID: 17474800
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment dexamethasone suppression test as a predictor of response to phenelzine.
Janicak PG; Pandey GN; Sharma R; Boshes R; Bresnahan D; Davis JM
J Clin Psychiatry; 1987 Dec; 48(12):480-2. PubMed ID: 3693333
[TBL] [Abstract][Full Text] [Related]
9. Cognitive performance in elderly subjects after a single dose of befloxatone, a new reversible selective monoamine oxidase A inhibitor.
Rosenzweig P; Patat A; Zieleniuk I; Cimarosti I; Allain H; Gandon JM
Clin Pharmacol Ther; 1998 Aug; 64(2):211-22. PubMed ID: 9728902
[TBL] [Abstract][Full Text] [Related]
10. MAO inhibition and clinical response in depressed patients treated with phenelzine.
Bresnahan DB; Pandey GN; Janicak PG; Sharma R; Boshes RA; Chang SS; Gierl BL; Davis JM
J Clin Psychiatry; 1990 Feb; 51(2):47-50. PubMed ID: 2298705
[TBL] [Abstract][Full Text] [Related]
11. Phenelzine treatment of melancholia.
McGrath PJ; Stewart JW; Harrison W; Wager S; Quitkin FM
J Clin Psychiatry; 1986 Aug; 47(8):420-2. PubMed ID: 3525522
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients.
Birkenhäger TK; van den Broek WW; Mulder PG; Bruijn JA; Moleman P
J Clin Psychiatry; 2004 Nov; 65(11):1505-10. PubMed ID: 15554763
[TBL] [Abstract][Full Text] [Related]
13. Relationship between response to phenelzine and MAO inhibition in a clinical trial of phenelzine, amitriptyline and placebo.
Raft D; Davidson J; Wasik J; Mattox A
Neuropsychobiology; 1981; 7(3):122-6. PubMed ID: 7231652
[TBL] [Abstract][Full Text] [Related]
14. MAOIs in the contemporary treatment of depression.
Thase ME; Trivedi MH; Rush AJ
Neuropsychopharmacology; 1995 May; 12(3):185-219. PubMed ID: 7612154
[TBL] [Abstract][Full Text] [Related]
15. Phenelzine for chronic depression: a study of continuation treatment.
Harrison W; Rabkin J; Stewart JW; McGrath PJ; Tricamo E; Quitkin F
J Clin Psychiatry; 1986 Jul; 47(7):346-9. PubMed ID: 3522558
[TBL] [Abstract][Full Text] [Related]
16. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
Chouinard G; Saxena BM; Nair NP; Kutcher SP; Bakish D; Bradwejn J; Kennedy SH; Sharma V; Remick RA; Kukha-Mohamad SA
Clin Neuropharmacol; 1993; 16 Suppl 2():S51-4. PubMed ID: 8313397
[TBL] [Abstract][Full Text] [Related]
17. Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant.
McGrath PJ; Stewart JW; Nunes EN; Quitkin FM
J Clin Psychiatry; 1994 Aug; 55(8):336-9. PubMed ID: 8071301
[TBL] [Abstract][Full Text] [Related]
18. Desipramine versus phenelzine in recurrent unipolar depression: clinical characteristics and treatment response.
Swann AC; Bowden CL; Rush AJ; Rhoades H; Rose R; Kobes R
J Clin Psychopharmacol; 1997 Apr; 17(2):78-83. PubMed ID: 10950467
[TBL] [Abstract][Full Text] [Related]
19. Differential response patterns to MAO inhibitors and tricyclics.
Nies A
J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487
[TBL] [Abstract][Full Text] [Related]
20. Combination monoamine oxidase inhibitor and beta-blocker treatment of migraine, with anxiety and depression.
Merikangas KR; Merikangas JR
Biol Psychiatry; 1995 Nov; 38(9):603-10. PubMed ID: 8573662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]